CASI Pharmaceuticals' Unattributed VC Round

CASI Pharmaceuticals raised a round of funding on , . Investors include Kleiner Perkins Caufield & Byers.

CASI Pharmaceuticals, formerly EntreMed, is a biopharmaceutical company focused on the acquisition, development, and commercialization of innovative therapeutics addressing CANCER and other unmet medi…

Articles about CASI Pharmaceuticals' Unattributed VC Round: